BACKGROUND: The Notch pathway is dysregulated in ovarian cancer. We sought to examine the role of Notch and gamma-secretase (GS) inhibition in ovarian cancer. MATERIALS AND METHODS: Established ovarian cancer cell lines were used. Quantitative polymerase chain reaction (qPCR) was used to determine the relative expression of Notch receptor and ligands. Effects of GS inhibition on proliferation, colony formation, and downstream effectors were examined via methylthiazole tetrazolium (MTT) and Matrigel assays, and qPCR, respectively. In vivo experiments with a GS inhibitor and cisplatin were conducted on nude mice. Tumors were examined for differences in microvessel density, proliferation, and apoptosis. RESULTS: Notch3 was the most up-regulated receptor. The ligands JAGGED1 and DELTA-LIKE4 were both up-regulated. GS inhibition did not affect cellular proliferation or anchorage-independent cell growth over placebo. The GS inhibitor Compound-E reduced microvessel density in vivo. CONCLUSION: GS inhibition does not directly affect cellular proliferation in ovarian carcinoma, but Notch pathway blockade may result in angiogenic alterations that may be therapeutically important.
BACKGROUND: The Notch pathway is dysregulated in ovarian cancer. We sought to examine the role of Notch and gamma-secretase (GS) inhibition in ovarian cancer. MATERIALS AND METHODS: Established ovarian cancer cell lines were used. Quantitative polymerase chain reaction (qPCR) was used to determine the relative expression of Notch receptor and ligands. Effects of GS inhibition on proliferation, colony formation, and downstream effectors were examined via methylthiazole tetrazolium (MTT) and Matrigel assays, and qPCR, respectively. In vivo experiments with a GS inhibitor and cisplatin were conducted on nude mice. Tumors were examined for differences in microvessel density, proliferation, and apoptosis. RESULTS:Notch3 was the most up-regulated receptor. The ligands JAGGED1 and DELTA-LIKE4 were both up-regulated. GS inhibition did not affect cellular proliferation or anchorage-independent cell growth over placebo. The GS inhibitor Compound-E reduced microvessel density in vivo. CONCLUSION:GS inhibition does not directly affect cellular proliferation in ovarian carcinoma, but Notch pathway blockade may result in angiogenic alterations that may be therapeutically important.
Authors: Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster Journal: Science Date: 2004-10-08 Impact factor: 47.728
Authors: V Fernández-Majada; C Aguilera; A Villanueva; F Vilardell; A Robert-Moreno; A Aytés; F X Real; G Capella; M W Mayo; L Espinosa; A Bigas Journal: Proc Natl Acad Sci U S A Date: 2006-12-26 Impact factor: 11.205
Authors: Joon T Park; Mei Li; Kentaro Nakayama; Tsui-Lien Mao; Ben Davidson; Zhen Zhang; Robert J Kurman; Charles G Eberhart; Ie-Ming Shih; Tian-Li Wang Journal: Cancer Res Date: 2006-06-15 Impact factor: 12.701
Authors: Stephen A Cannistra; Ursula A Matulonis; Richard T Penson; Julie Hambleton; Jakob Dupont; Howard Mackey; Jeffrey Douglas; Robert A Burger; Deborah Armstrong; Robert Wenham; William McGuire Journal: J Clin Oncol Date: 2007-11-20 Impact factor: 44.544
Authors: Robert A Burger; Michael W Sill; Bradley J Monk; Benjamin E Greer; Joel I Sorosky Journal: J Clin Oncol Date: 2007-11-20 Impact factor: 44.544
Authors: Jacques B de Kok; Rian W Roelofs; Belinda A Giesendorf; Jeroen L Pennings; Erwin T Waas; Ton Feuth; Dorine W Swinkels; Paul N Span Journal: Lab Invest Date: 2005-01 Impact factor: 5.662
Authors: Jason Roszik; Anil K Sood; Alejandro Villar-Prados; Sherry Y Wu; Karem A Court; Shaolin Ma; Christopher LaFargue; Mamur A Chowdhury; Margaret I Engelhardt; Cristina Ivan; Prahlad T Ram; Ying Wang; Keith Baggerly; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Shyh Ming-Yang; David J Maloney; Makoto Yoshioka; Jeffrey W Strovel Journal: Mol Cancer Ther Date: 2018-11-12 Impact factor: 6.261
Authors: Ved P Sharma; Binwu Tang; Yarong Wang; Camille L Duran; George S Karagiannis; Emily A Xue; David Entenberg; Lucia Borriello; Anouchka Coste; Robert J Eddy; Gina Kim; Xianjun Ye; Joan G Jones; Eli Grunblatt; Nathan Agi; Sweta Roy; Gargi Bandyopadhyaya; Esther Adler; Chinmay R Surve; Dominic Esposito; Sumanta Goswami; Jeffrey E Segall; Wenjun Guo; John S Condeelis; Lalage M Wakefield; Maja H Oktay Journal: Nat Commun Date: 2021-12-15 Impact factor: 14.919
Authors: Jolijn W Groeneweg; Rosemary Foster; Whitfield B Growdon; René H M Verheijen; Bo R Rueda Journal: J Ovarian Res Date: 2014-11-04 Impact factor: 4.234